# A phase II trial of huperzine A in mild to moderate Alzheimer disease

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-phase-ii-trial-of-huperzine-a-in-mild-to-moderate-alzheimer-disease/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Michael S. Rafii,Sally Walsh,John T. Little,K A Behan,Brigid Reynolds,Carwyn Ward,Shelia Jin,Ronald G. Thomas,Paul Aisen,For the Alzheimer's Disease Cooperative Study |
| Citations | 236 |
| DOI | 10.1212/wnl.0b013e318216eb7b |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://n.neurology.org/content/neurology/76/16/1389.full.pdf |
| OpenAlex ID | https://openalex.org/W2049190733 |
| PMID | 21502597 |
| Type | article |
| Year | 2011 |

## Paper authors

- [Carwyn Ward](https://scholariq.org/researchers/carwyn-ward/)

## Paper journal

- [Neurology](https://scholariq.org/journals/neurology/)

## Paper primary topic

- [Cholinesterase and Neurodegenerative Diseases](https://scholariq.org/topics/cholinesterase-and-neurodegenerative-diseases/)

## Paper topics

- [Cholinesterase and Neurodegenerative Diseases](https://scholariq.org/topics/cholinesterase-and-neurodegenerative-diseases/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Nicotinic Acetylcholine Receptors Study](https://scholariq.org/topics/nicotinic-acetylcholine-receptors-study/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.